How breast radiotherapy technique works best for each patient

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study enrolls at least 30 female patients with left breast cancer to compare three planned radiotherapy techniques. Each patient will have 90 treatment plans simulated (three plans per patient) and the best technique will be chosen by at least three expert clinicians using a scoring system. No changes to standard clinical practice will be made and all data reflect routine care collected during treatment planning and follow-up. The study aims to identify objective criteria that could guide future selection of radiotherapy techniques for individual patients. The duration is expected to be about 30 months and all treatments will use a dose of 40.05 Gy in 15 fractions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Female
* Target volume: left breast
* Tumor type: any diagnosis of breast cancer
* Dose prescription: 40.05 Gray/15 fractions
* Patients aged ≥ 18 years old
* Patients willing and able to give informed consent to participate

Exclusion Criteria:

* Other concomitant tumor lesions
* Sovraclavear lymph node involvement

Where it's running

• Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS
  Meldola, Fc, Italy Recruiting

Study contacts

• Study coordinator: Oriana Nanni
• Email: oriana.nanni@irst.emr.it

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.